Riley JP - Search Results

1

Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.

Riley JP, Rosenberg SA, Parkhurst MR. Riley JP, et al. J Immunother. 2001 May-Jun;24(3):212-20. J Immunother. 2001. PMID: 11394498

2

Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.

Liu S, Riley J, Rosenberg S, Parkhurst M. Liu S, et al. J Immunother. 2006 May-Jun;29(3):284-93. doi: 10.1097/01.cji.0000190168.53793.6b. J Immunother. 2006. PMID: 16699371

3

Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.

Lotem M, Zhao Y, Riley J, Hwu P, Morgan RA, Rosenberg SA, Parkhurst MR. Lotem M, et al. J Immunother. 2006 Nov-Dec;29(6):616-27. doi: 10.1097/01.cji.0000211312.36363.56. J Immunother. 2006. PMID: 17063124 Free PMC article.

4

Identification of a New Shared HLA-A2.1 Restricted Epitope From the Melanoma Antigen Tyrosinase.

Riley JP, Rosenberg SA, Parkhurst MR. Riley JP, et al. J Immunother (1991). 2001 May;24(3):212-220. J Immunother (1991). 2001. PMID: 11395636

5

Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy.

Rosenberg SA, Tong-On P, Li Y, Riley JP, El-Gamil M, Parkhurst MR, Robbins PF. Rosenberg SA, et al. Among authors: riley jp. J Immunol. 2002 Mar 1;168(5):2402-7. doi: 10.4049/jimmunol.168.5.2402. J Immunol. 2002. PMID: 11859131 Free PMC article.

6

Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S. Parkhurst MR, et al. Among authors: riley jp. J Immunol. 2003 May 15;170(10):5317-25. doi: 10.4049/jimmunol.170.10.5317. J Immunol. 2003. PMID: 12734382 Free PMC article.

7

Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinities.

Riley JP, Rosenberg SA, Parkhurst MR. Riley JP, et al. J Immunol Methods. 2003 May 1;276(1-2):103-19. doi: 10.1016/s0022-1759(03)00078-4. J Immunol Methods. 2003. PMID: 12738363

8

Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein.

Parkhurst MR, Riley JP, Robbins PF, Rosenberg SA. Parkhurst MR, et al. Among authors: riley jp. J Immunother. 2004 Mar-Apr;27(2):79-91. doi: 10.1097/00002371-200403000-00001. J Immunother. 2004. PMID: 14770079 Free PMC article.

9

Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase.

Parkhurst MR, Riley JP, Igarashi T, Li Y, Robbins PF, Rosenberg SA. Parkhurst MR, et al. Among authors: riley jp. Clin Cancer Res. 2004 Jul 15;10(14):4688-98. doi: 10.1158/1078-0432.CCR-04-0325. Clin Cancer Res. 2004. PMID: 15269141 Free PMC article. Clinical Trial.

10

Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.

Parkhurst MR, Joo J, Riley JP, Yu Z, Li Y, Robbins PF, Rosenberg SA. Parkhurst MR, et al. Among authors: riley jp. Clin Cancer Res. 2009 Jan 1;15(1):169-80. doi: 10.1158/1078-0432.CCR-08-1638. Clin Cancer Res. 2009. PMID: 19118044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters